A study on Kana kudineer for wheezing (childhood asthma)

Phase II Non randomized clinical study on Sooli kanam (Childhood bronchial asthma) in children with the evaluation of siddha trial drug kana kudineer - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058061

Enrollment

Registered

2023-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: KANA KUDINEER (INTERNAL): Kana kudineer 15 to 30 ml twice a day for 21 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Cough with expectoration Dyspnea Running nose or rhinitis Chest tightness Wheezing

Exclusion criteria

Exclusion criteria: Primary complex Hypersensitivity pneumonitis Lung abscess Cystic fibrosis Bronchiolitis

Design outcomes

Primary

Measure	Time frame
Assesed by comparing the reduction in clinical symptoms & modified asthma scale before & after treatmentTimepoint: 21 days	—

Secondary

Measure	Time frame
Assessed by comparing the safety parameters before & after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactSimal S

Government siddha medical college

cspriya2004@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026